New Study Challenges 'Lower Is Better' Blood Pressure Guidelines for Hypertension

A new study published in Nature Communications is reshaping how doctors approach blood pressure management. Led by Zhang, R., Lam, I.C.H., Emilsson, L., and colleagues, the research questions the long-held belief that lower blood pressure is always better for patients with uncomplicated hypertension. The findings suggest that a more tailored approach could improve outcomes while minimising risks. Hypertension remains a leading global health concern, contributing to millions of cases of heart disease and stroke each year. Despite its prevalence, the ideal blood pressure target for patients without major complications has stayed unclear.

The team analysed real-world data using an innovative *target trial emulation* method. This approach simulated the effects of different blood pressure goals, providing insights usually reserved for lengthy clinical trials. The study focused on adults with uncomplicated hypertension—those without severe comorbidities. Results showed that a moderate blood pressure target significantly cut the risk of strokes and heart attacks. Importantly, this benefit came without a sharp rise in side effects. The research also identified specific patient subgroups that might respond better to particular targets, paving the way for more personalised treatment plans. Experts have welcomed the findings, calling them a potential turning point in hypertension care. By using existing health records, the study demonstrates how real-world data can answer critical medical questions faster than traditional trials.

The study challenges the one-size-fits-all approach to blood pressure control. Its findings suggest that moderate targets may offer the best balance of protection and safety for many patients. Clinicians now have stronger evidence to guide individualised treatment, though further research will help refine these recommendations.